These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19775334)

  • 1. Targeted tailored management of the breast cancer patient at risk for harboring a germline mutation-current trends affecting the selection of patients considering surgical prophylaxis for breast cancer.
    Silva E
    Breast J; 2009; 15 Suppl 1():S76-80. PubMed ID: 19775334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic mastectomy and genetic testing: an update.
    Houshmand SL; Campbell CT; Briggs SE; McFadden AW; Al-Tweigeri T
    Oncol Nurs Forum; 2000; 27(10):1537-47; quiz 1548-9. PubMed ID: 11103373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
    Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
    J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can genetic testing guide treatment in breast cancer?
    Tutt A; Ashworth A
    Eur J Cancer; 2008 Dec; 44(18):2774-80. PubMed ID: 19027287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic counseling and management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations.
    Silva E; Lynch H
    Breast J; 2006; 12(3):280-1; author reply 282-4. PubMed ID: 16684334
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hereditary breast cancer: treatment and prevention].
    Ejlertsen B; Gerdes AM
    Ugeskr Laeger; 2007 Sep; 169(36):2972-5. PubMed ID: 17953871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of the BRCA mutation carrier or high-risk patient.
    Bordeleau LJ; Lipa JE; Neligan PC
    Clin Plast Surg; 2007 Jan; 34(1):15-27; abstract v. PubMed ID: 17307068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prophylactic mastectomies and immediate breast reconstruction in patients at very high genetic risk: our experience with 14 cases].
    Missana MC; Chompret A
    Ann Chir Plast Esthet; 2008 Aug; 53(4):325-33. PubMed ID: 18055089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Best surgical prophylaxis--risk-reducing mastectomy for women at high personal risk of breast cancer.
    Baildam AD
    Breast; 2006 Dec; 15 Suppl 2():S21-5. PubMed ID: 17382857
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylactic mastectomy.
    Zakaria S; Degnim AC
    Surg Clin North Am; 2007 Apr; 87(2):317-31, viii. PubMed ID: 17498529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
    Forman AD; Hall MJ
    Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevention of hereditary breast cancer.
    Rodriquez E; Domchek SM
    Semin Oncol; 2007 Oct; 34(5):401-5. PubMed ID: 17920894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contralateral Prophylactic Mastectomy Overtreatment: Expectations from Personal Genomics for Tailored Breast Cancer Surgery.
    Zografos GC; Roukos DH
    Ann Surg Oncol; 2010 Mar; 17(3):939; author reply 940. PubMed ID: 19937131
    [No Abstract]   [Full Text] [Related]  

  • 14. Decision making regarding prophylactic mastectomy: stability of preferences and the impact of anticipated feelings of regret.
    van Dijk S; van Roosmalen MS; Otten W; Stalmeier PF
    J Clin Oncol; 2008 May; 26(14):2358-63. PubMed ID: 18467728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI in breast cancer management: potential for benefit and harm.
    Jatoi I
    Int J Fertil Womens Med; 2005; 50(6):281-4. PubMed ID: 16526420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic counseling and the advanced practice oncology nursing role in a hereditary cancer prevention clinic: hereditary breast cancer focus (part II).
    Lynch HT; Snyder CL; Lynch JF
    Breast J; 2009; 15 Suppl 1():S11-9. PubMed ID: 19775324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lesser evil: prophylactic mastectomy for women at high risk for breast cancer.
    Schover LR
    J Clin Oncol; 2008 Aug; 26(24):3918-9. PubMed ID: 18711178
    [No Abstract]   [Full Text] [Related]  

  • 18. MR imaging for surveillance of women at high familial risk for breast cancer.
    Kuhl CK
    Magn Reson Imaging Clin N Am; 2006 Aug; 14(3):391-402, vii. PubMed ID: 17098180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic counseling and the advanced practice oncology nursing role in a hereditary cancer prevention clinic: hereditary breast cancer focus (part I).
    Snyder CL; Lynch JF; Lynch HT
    Breast J; 2009; 15 Suppl 1():S2-10. PubMed ID: 19775325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary breast and ovarian cancer syndrome.
    ACOG Committee on Practice Bulletins
    Gynecol Oncol; 2009 Apr; 113(1):6-11. PubMed ID: 19309638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.